Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Nitrogen Binding Agent [EPC]
Glycolic Acid is a Nitrogen Binding Agent [EPC] utilized primarily for its Ammonium Ion Binding Activity [MoA] to manage nitrogen levels in patients with specific metabolic disorders.
Name
Glycolic Acid
Raw Name
GLYCOLIC ACID
Category
Nitrogen Binding Agent [EPC]
Drug Count
3
Variant Count
3
Last Verified
February 17, 2026
About Glycolic Acid
Glycolic Acid is a Nitrogen Binding Agent [EPC] utilized primarily for its Ammonium Ion Binding Activity [MoA] to manage nitrogen levels in patients with specific metabolic disorders.
Detailed information about Glycolic Acid
References used for this content
This page is for informational purposes only and does not replace medical advice. Consult a qualified healthcare professional before using any medication containing Glycolic Acid.
Historically, the FDA approval of nitrogen-binding agents has revolutionized the management of rare metabolic diseases. Glycolic Acid functions by conjugating with specific amino acids to form molecules that the kidneys can easily filter and excrete. By doing so, it prevents the accumulation of toxic ammonium ions, which can otherwise lead to encephalopathy (brain dysfunction), permanent neurological damage, or coma. Patients prescribed this medication typically require lifelong management and a highly controlled diet. It is essential to understand that this medication is not a cure but a chronic management strategy to maintain metabolic stability.
The primary mechanism of action for Glycolic Acid is its Ammonium Ion Binding Activity [MoA]. At the molecular level, Glycolic Acid acts as a prodrug or a metabolic intermediary that facilitates the removal of nitrogen. When nitrogen enters the body through protein consumption, it is normally converted into urea by the liver. In patients with urea cycle deficiencies, this process is interrupted, leading to a buildup of ammonia ($NH_3$).
Glycolic Acid works by undergoing rapid metabolism to form an active conjugate. This conjugate binds with glutamine—an amino acid that acts as a reservoir for waste nitrogen. The resulting compound, often a glycolyl-glutamine derivative, is water-soluble and is cleared by the kidneys via glomerular filtration and tubular secretion. By removing one molecule of glutamine, the drug effectively removes two atoms of nitrogen from the systemic circulation. This 'alternative pathway' is vital because it reduces the precursor load on the urea cycle, thereby lowering the overall plasma ammonia concentration. This biochemical 'shunting' is the cornerstone of preventing hyperammonemic crises.
Understanding the pharmacokinetics of Glycolic Acid is essential for optimizing therapeutic outcomes and minimizing toxicity.
Glycolic Acid is primarily indicated for the chronic management of patients with urea cycle disorders (UCDs) involving deficiencies of specific enzymes such as carbamoyl phosphate synthetase (CPS), ornithine transcarbamylase (OTC), or argininosuccinate synthetase (AS).
Glycolic Acid is available in several formulations to accommodate different patient needs, particularly given that many patients are in the pediatric population:
> Important: Only your healthcare provider can determine if Glycolic Acid is right for your specific condition. This medication must be used in conjunction with a low-protein diet and under the strict supervision of a metabolic specialist.
The dosage of Glycolic Acid for adults is highly individualized and is based on the patient's body surface area (BSA) or total body weight, as well as their residual urea cycle enzyme activity.
Pediatric dosing is critical as children are often the primary recipients of this therapy for genetic disorders.
Since Glycolic Acid is primarily excreted by the kidneys, patients with renal insufficiency require significant dose reductions. In cases of severe renal failure or end-stage renal disease (ESRD), the drug may be contraindicated or require use only in conjunction with dialysis, as the toxic metabolites can accumulate rapidly.
Because the liver is the site of the initial metabolic processing of nitrogen and the drug itself, patients with hepatic impairment (e.g., cirrhosis) may have altered drug clearance. While no specific formula for adjustment exists, close monitoring of plasma glutamine and ammonia levels is mandatory.
Clinical studies have not included sufficient numbers of subjects aged 65 and over to determine whether they respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function.
Glycolic Acid must be taken exactly as prescribed to be effective.
If you miss a dose, take it as soon as you remember, provided it is within 2 hours of the missed time. If it is almost time for your next dose, skip the missed dose and resume your regular schedule. Do not double the dose to catch up. Frequent missed doses can lead to a dangerous rise in ammonia levels, which may require hospitalization.
An overdose of Glycolic Acid can lead to metabolic acidosis and neurotoxicity.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance. Regular laboratory monitoring is the only way to ensure the dose is safe and effective.
Glycolic Acid therapy is often associated with gastrointestinal and metabolic adjustments as the body adapts to the nitrogen-shunting process.
> Warning: Stop taking Glycolic Acid and call your doctor immediately if you experience any of these serious symptoms.
With prolonged use, Glycolic Acid may impact several body systems:
No FDA black box warnings for Glycolic Acid have been issued as of 2026. However, the medication carries significant warnings regarding its use in patients with heart failure or renal impairment due to the potential for sodium loading (if the salt form is used) and metabolite accumulation.
Report any unusual symptoms to your healthcare provider. Your doctor may adjust your dose or provide supportive treatments to manage these side effects.
Glycolic Acid is a high-alert medication that requires precise management. It must never be used as a standalone treatment for acute hyperammonemia (an emergency medical crisis where ammonia levels are dangerously high), as it does not lower ammonia levels fast enough to prevent brain damage in an acute setting. Acute crises require hemodialysis and intravenous interventions in a hospital environment.
No FDA black box warnings for Glycolic Acid. However, it is important to note that the related class of nitrogen binders often carries warnings about the risk of neurotoxicity if doses exceed the recommended range.
To ensure safety, patients on Glycolic Acid require regular laboratory monitoring:
Glycolic Acid may cause dizziness, fatigue, or 'brain fog' in some patients. Do not drive, operate heavy machinery, or engage in dangerous activities until you know how this medication affects you. If you experience any changes in mental clarity, contact your doctor immediately.
Alcohol should be strictly avoided while taking Glycolic Acid. Alcohol can interfere with liver function, potentially worsening hyperammonemia, and can also increase the risk of gastrointestinal side effects and dehydration, which can be dangerous for patients with urea cycle disorders.
Never stop taking Glycolic Acid abruptly. Discontinuing the medication can lead to a rapid and life-threatening rise in ammonia levels. If the medication must be stopped, it must be done under the direct supervision of a metabolic specialist, usually in a hospital setting where ammonia levels can be monitored hourly.
> Important: Discuss all your medical conditions with your healthcare provider before starting Glycolic Acid, especially if you have a history of heart, liver, or kidney disease.
Certain medications must NEVER be used with Glycolic Acid because they can cause life-threatening interactions:
Glycolic Acid therapy can interfere with the accuracy of certain laboratory tests:
For each major interaction, the mechanism typically involves either pharmacodynamic antagonism (the drugs have opposite effects on ammonia) or pharmacokinetic competition (the drugs fight for the same exit through the kidneys). The clinical consequence is usually either a dangerous rise in ammonia (reduced efficacy) or an increase in neurotoxicity (increased toxicity).
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking. Even over-the-counter cold medicines can sometimes contain ingredients that affect nitrogen metabolism.
There are specific circumstances where Glycolic Acid must NEVER be used because the risks far outweigh any potential benefits:
In these situations, the healthcare provider must perform a careful risk-benefit analysis:
Patients who have shown sensitivity to other nitrogen-binding agents, such as sodium phenylbutyrate or glycerol phenylbutyrate, may exhibit cross-sensitivity to Glycolic Acid due to similarities in the metabolic pathways and chemical structures involved in nitrogen conjugation.
> Important: Your healthcare provider will evaluate your complete medical history, including kidney function and heart health, before prescribing Glycolic Acid. Always disclose any history of allergic reactions to medications.
Glycolic Acid is generally classified under Pregnancy Category C. There are no adequate and well-controlled studies in pregnant women. Animal reproduction studies have shown some evidence of embryofetal toxicity at high doses. However, untreated urea cycle disorders in the mother pose a significant risk of maternal death and fetal injury due to hyperammonemia.
It is not known whether Glycolic Acid or its metabolites are excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants (including neurotoxicity), a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
Glycolic Acid is FDA-approved for use in children of all ages, including neonates, for the management of urea cycle disorders.
Clinical experience with Glycolic Acid in patients aged 65 and older is limited. Geriatric patients are more likely to have decreased renal function. Since the drug is cleared by the kidneys, the risk of toxic reactions is greater in patients with impaired renal function. Dose selection should be conservative, and renal function (Creatinine Clearance) should be monitored regularly.
In patients with mild to moderate renal impairment, the dose of Glycolic Acid should be reduced. In patients with a GFR (Glomerular Filtration Rate) of less than 30 mL/min, the drug should be used with extreme caution or avoided. Dialysis can remove the drug, so dosing should be timed around dialysis sessions if applicable.
Since the liver is responsible for the initial processing of nitrogen and the drug's conjugation, patients with hepatic impairment (Child-Pugh Class B or C) may have unpredictable drug levels. Close monitoring of plasma ammonia and glutamine is the only safe way to manage these patients.
> Important: Special populations require individualized medical assessment. Never share this medication with others, as their metabolic needs and risks will be different from yours.
Glycolic Acid functions as a nitrogen scavenger. Its molecular mechanism involves its conversion into a metabolite that undergoes enzymatic conjugation with the amino acid glutamine. This reaction is catalyzed by the enzyme glutamine N-acyltransferase, primarily in the liver and kidneys. Each molecule of the resulting conjugate contains two nitrogen atoms. By facilitating the excretion of this conjugate in the urine, Glycolic Acid provides an alternative pathway for nitrogen waste removal, effectively bypassing the deficient urea cycle. This prevents the accumulation of ammonium ions ($NH_4^+$), which are highly neurotoxic.
The pharmacodynamic effect of Glycolic Acid is the reduction of plasma ammonia and glutamine levels. The onset of effect is relatively rapid, with significant reductions in ammonia seen within 24 to 48 hours of starting therapy. However, the duration of effect is short, and ammonia levels can rise within hours if a dose is missed. There is a clear dose-response relationship; however, once the available glutamine pool is saturated, increasing the dose further does not result in more nitrogen removal and instead increases the risk of neurotoxicity.
| Parameter | Value |
|---|---|
| Bioavailability | >80% |
| Protein Binding | 30% - 40% (mainly Albumin) |
| Half-life | 2 - 5 hours |
| Tmax | 1 - 2 hours |
| Metabolism | Hepatic/Renal conjugation with Glutamine |
| Excretion | Renal >90% |
Glycolic Acid is categorized as a Nitrogen Binding Agent [EPC]. It is therapeutically related to medications such as Sodium Phenylbutyrate (Buphenyl) and Glycerol Phenylbutyrate (Ravicti). These drugs are all designed to manage hyperammonemia by creating alternative nitrogen excretion pathways.
Common questions about Glycolic Acid
Glycolic Acid is primarily used as a nitrogen-binding agent to treat patients with urea cycle disorders (UCDs). These are rare genetic conditions where the body cannot properly remove ammonia, a toxic waste product of protein metabolism. By binding to nitrogen-containing compounds in the blood, Glycolic Acid helps the kidneys excrete waste that the liver cannot process. This prevents the buildup of ammonia, which can cause brain damage, coma, or death. It is used as a long-term maintenance medication alongside a strictly controlled low-protein diet. It is not used for the emergency treatment of sudden, life-threatening ammonia spikes.
The most common side effects of Glycolic Acid include gastrointestinal issues such as nausea, vomiting, abdominal pain, and diarrhea. Many patients also experience a persistent unpleasant or metallic taste in their mouth, which can affect their appetite. In women, the medication frequently causes menstrual irregularities or the complete absence of periods. Headaches and a general feeling of tiredness are also frequently reported, especially when first starting the drug. Most of these symptoms are manageable, but you should always report them to your doctor to ensure your dosage is correct.
No, you should not drink alcohol while taking Glycolic Acid. Alcohol can significantly impair liver function, which is already compromised or under stress in patients with urea cycle disorders. Furthermore, alcohol consumption can lead to dehydration and metabolic imbalances that may trigger a hyperammonemic crisis (a dangerous rise in ammonia). Alcohol can also worsen the gastrointestinal side effects of the medication, such as nausea and stomach pain. For your safety, it is best to avoid all alcoholic beverages while on this therapy.
Glycolic Acid is generally used during pregnancy only if the potential benefit to the mother outweighs the potential risk to the fetus. While animal studies have shown some risks, untreated high ammonia levels in a pregnant woman are extremely dangerous for both the mother and the baby. If you are planning to become pregnant or find out you are pregnant, you must contact your metabolic specialist immediately. They will work with a high-risk obstetrician to monitor your ammonia levels very closely throughout the pregnancy. Your dosage may need to be adjusted frequently to ensure both your safety and the healthy development of the fetus.
Glycolic Acid begins to work relatively quickly, with the drug reaching peak levels in the blood within 1 to 2 hours of taking a dose. You may see a reduction in blood ammonia levels within 24 to 48 hours of starting the medication. However, because it works by binding to nitrogen from the food you eat, its effectiveness is continuous and depends on taking the medication with every meal. It does not provide a permanent 'fix' for ammonia; if you stop taking it, ammonia levels can begin to rise again within a few hours. Regular blood tests are the only way to confirm the medication is working as intended.
You must never stop taking Glycolic Acid suddenly unless specifically instructed by a metabolic specialist in a hospital setting. Stopping the medication abruptly can cause a rapid, dangerous increase in ammonia levels, leading to a medical emergency known as a hyperammonemic crisis. Symptoms of this can include vomiting, confusion, loss of coordination, and eventually coma. If you are having trouble with side effects or cannot afford the medication, talk to your doctor immediately to find a safe solution. Your life depends on the consistent removal of nitrogen that this medication provides.
If you miss a dose of Glycolic Acid, take it as soon as you remember, as long as it is within about 2 hours of the scheduled time. If it is almost time for your next dose, skip the missed dose and return to your regular schedule. Do not take two doses at once to make up for a missed one. Because this medication works to clear nitrogen from the protein in your meals, missing a dose can allow ammonia to build up. If you miss multiple doses, contact your healthcare provider immediately for guidance and watch for signs of high ammonia, such as headache or nausea.
Glycolic Acid itself is not typically associated with weight gain. In fact, many patients experience a decrease in appetite or nausea, which can lead to weight loss. However, because patients on this medication must follow a very specific diet that is often high in carbohydrates to provide enough calories while restricting protein, weight changes can occur due to dietary factors. In children, weight gain is a positive sign of growth and is monitored closely. If you notice sudden or unexplained weight changes, discuss them with your doctor or a specialized metabolic dietitian.
Glycolic Acid can interact with several other medications, some of which are very common. For example, steroids like prednisone and certain seizure medications like valproic acid can interfere with how your body handles nitrogen, making Glycolic Acid less effective. Other drugs, like probenecid, can slow down the removal of Glycolic Acid from your body, leading to side effects. Always provide your doctor and pharmacist with a complete list of all medications, including over-the-counter drugs and herbal supplements. They will check for interactions to ensure your treatment remains safe and effective.
Whether Glycolic Acid is available as a generic depends on the specific formulation and the country you are in. In many cases, nitrogen-binding agents are considered 'orphan drugs' because they treat rare diseases, which can affect the availability of generic versions. However, some older formulations of nitrogen scavengers do have generic equivalents, which can be significantly less expensive. You should check with your pharmacist or insurance provider to see if a generic version is available and if it is suitable for your specific condition. Always ensure that any generic switch is approved by your metabolic specialist.